Join our newsletter. Sign up today


Publications and related articles about Lunaphore Technologies and the industry in general.

Lunaphore closes a CHF 5.3M Series B financing round

In Press Releases

Lunaphore Technologies SA, a Swiss medtech firm developing innovative next-generation devices for cancer tissue diagnostics*, announces closing of CHF 5.3M in Series B funding. Together with the CHF 6M convertible loan injected to the company in October 2017, the overall financing round amount has reached CHF 11.3M.

Read the full press release

Share this

Hi! We use cookies to improve this website. By continuing to use our services, you are giving us your consent to use cookies. Learn more about our privacy policy and our terms of use.
I agree